Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Grants and Contributions Dataset
Found 1229 records

$15,000.00

Mar 19, 2024

For-profit organization

Description:

Develop digital adoption plan

Organization: Innovation, Science and Economic Development Canada
Program Name: Canadian Digital Adoption Program Boost your Business Technology Stream
Location: GLOUCESTER, Ontario, CA K1V1H5

$366,946.00

Mar 14, 2024

Academia

Agreement:

AAV Gene Therapy for the Treatment of Lipoprotein Lipase Deficiency

Agreement Number:

1014773

Duration: from Mar 14, 2024 to Mar 1, 2025
Description:

The project will lead to an improved and more cost-effective AAV-LPL gene therapy for the treatment of Lipoprotein Lipase (LPL) Deficiency.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Vancouver, British Columbia, CA V6T 1Z3

For-profit organization

Description:

Develop digital adoption plan

Organization: Innovation, Science and Economic Development Canada
Program Name: Canadian Digital Adoption Program Boost your Business Technology Stream
Location: NORTH YORK, Ontario, CA M3B2T5

$14,175.00

Feb 20, 2024

For-profit organization

Description:

Develop digital adoption plan

Organization: Innovation, Science and Economic Development Canada
Program Name: Canadian Digital Adoption Program Boost your Business Technology Stream
Location: ST. ALBERT, Alberta, CA T8N5T8

$691,045.00

Feb 20, 2024

Not-for-profit organization or charity

Agreement:

Development and application of qualified testing in support of Clinical CAR-T Products

Agreement Number:

1015631

Duration: from Feb 20, 2024 to Mar 10, 2026
Description:

In the Project, OHRI will build on their success in establishing clinical grade manufacturing for both lentivirus and cell products, and the execution of the first clinical trial using a made-in-Canada CD19 CAR T-cell therapy. The project includes building capacity in point-of-care (POC) manufacturing to support the clinical rollout of novel CAR T-cell products and other personalized cell therapy products.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Ottawa, Ontario, CA K1Y 4E9

$24,894.00

Feb 19, 2024

For-profit organization

Agreement:

Patent Filings for New Applications of Sona Gold Nanorods for Targeted Hyperthermia Therapy and Other Applications

Agreement Number:

1015813

Duration: from Feb 19, 2024 to May 27, 2024
Description:

Sona Nanotech Inc. has a patented and patent-pending technology for manufacturing biocompatible, toxin-free gold nanorods. The goal of the intellectual property work outlined in this proposal is to enable Sona to file additional patent(s) covering new capabilities of the nanorods. The deliverables of this project will be a patent landscape report that includes patent search details, patent publication level results, patent assignee analysis, subject matter analysis, country analysis, and date analysis. This report will then be used to formulate and refine a strategy for Sona's next patent filings, starting with provisional patent filings to establish a priority date for the inventions disclosed in the application.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Halifax, Nova Scotia, CA B3J 3R7

For-profit organization

Description:

Develop digital adoption plan

Organization: Innovation, Science and Economic Development Canada
Program Name: Canadian Digital Adoption Program Boost your Business Technology Stream
Location: MONTRÉAL, Quebec, CA H4A3L5

For-profit organization

Description:

Develop digital adoption plan

Organization: Innovation, Science and Economic Development Canada
Program Name: Canadian Digital Adoption Program Boost your Business Technology Stream
Location: TORONTO, Ontario, CA M4S2A3

For-profit organization

Description:

Develop digital adoption plan

Organization: Innovation, Science and Economic Development Canada
Program Name: Canadian Digital Adoption Program Boost your Business Technology Stream
Location: TORONTO, Ontario, CA M5R3H8

$450,000.00

Feb 1, 2024

For-profit organization

Agreement:

CIIP Korea - MTD-TPC - Music Therapy Devices for Mental Health: A Trans-Pacific Collaboration

Agreement Number:

1015298

Duration: from Feb 1, 2024 to Apr 23, 2026
Description:

LUCID, a Canadian digital health startup, and Emma Healthcare, a Korean SME specializing in advanced diagnostics, are collaborating to revolutionize neuropsychiatric care through the co-development of an AI-based music therapy solution. LUCID's BioMIR technology, which analyzes user data and predicts emotional and cognitive states to personalize digital music therapy, will be enhanced with Emma Healthcare's diagnostic capabilities and measurement expertise. This joint effort aims to optimize the effectiveness of the therapy offering by training it on diverse datasets from North American and Asian populations, ultimately providing personalized, clinically validated music therapy solutions for improved mental well-being worldwide.

Organization: National Research Council Canada
Program Name: Canadian International Innovation Program
Location: Toronto, Ontario, CA M5C 1K9